Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphomaPR Newswire•10/08/2026•02:32 ET0 ShareWhiz InsightsGenerateGet startedCreate a free account to read the full story.Sign UpAlready have an account? Log inForgot password?
